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Corneal Cross-Linking in a 4-Year-Old Child With
Keratoconus and Down Syndrome
Saad Sabti, MD, Christoph Tappeiner, MD, and Beatrice E. Frueh, MD
Purpose: To describe the clinical outcome of corneal cross-linking
(CXL) in a young child with keratoconus.
Methods: This is a case report of a young girl with keratoconus
with ophthalmologic ﬁndings and 3-year follow-up. Follow-up visits
included visual acuity measurement, retinoscopy, corneal tomogra-
phy, and topography.
Results: A girl with Down syndrome was diagnosed with bilateral
keratoconus and relative amblyopia at the age of 4 years. The best-
corrected near visual acuity was 20/100 binocularly. Corneal
tomography showed the following parameters: OD Kmax 47.2
diopters (D), thinnest location 442 mm; OS Kmax 49.6 D, thinnest
location 432 mm. Three months later, the keratoconus in the left eye
progressed (Kmax 50.2 D, thinnest location 424 mm), and CXL was
performed. One year later, CXL was necessary also in the right eye
because of progression. The girl was most recently reexamined at the
age of 7 years. The corrected near visual acuity was 20/80 in both
eyes. The corneal curvature slightly ﬂattened, and the corneal
thickness stabilized (OD Kmax 46.8 D, thinnest location 389 mm;
OS Kmax 49.4 D, thinnest location 360 mm).
Conclusions: Onset of keratoconus can occur in early childhood,
especially in patients with Down syndrome. In this case, CXL was
performed at 4 and 5 years of age without complications and stopped
further keratoconus progression.
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Keratoconus is a noninﬂammatory corneal dystrophycharacterized by changes in the collagen structure and
organization. Reduced collagen cross-linking and increased
pepsin digestion are probably responsible for the structural
weakness of the cornea, which in the case of keratoconus has
a stiffness of only 60% of the normal cornea.1 The reduced
mechanical stability of the cornea leads to ectasia with
impaired vision caused by irregular astigmatism, progressive
myopia, corneal thinning, and occasionally corneal scarring.
Corneal cross-linking (CXL) with riboﬂavin and UV-A
irradiation has been established as an effective treatment
option. CXL has been demonstrated to stop the progression of
keratoconus in both adults and children, possibly avoiding the
need for keratoplasty.2–4 Especially in children, keratoconus is
often more advanced at the time of diagnosis than in adults
and progresses more rapidly.5 We report the case of a girl with
Down syndrome, who was diagnosed with bilateral kerato-
conus and secondary amblyopia at the age of 4 years. Because
of documented progression, a decision to perform CXL in
early childhood was made.
CASE REPORT
A 4-year-old girl with Down syndrome had been referred by
an attentive ophthalmologist for the assessment of astigmatism
and suspiciously distorted light reﬂexes in retinoscopy in both
eyes. At the ﬁrst presentation, cycloplegic retinoscopy showed
a refractive error of 20.5/21.75/93° for the right eye and
+3.0/23.0/98° for the left eye. The best-corrected near visual
acuity was 20/100 binocularly. Slit-lamp examination showed
bilateral central thinning of the cornea and Vogt striae in the
paracentral area. Corneal tomographies and topographies with the
Oculus Pentacam (Oculus, Wetzlar, Germany) and Tomey TMS 4
(Tomey, Erlangen, Germany) were performed. Tomography
showed a maximal curvature (Kmax) of 47.2 diopters (D), with
a thinnest corneal thickness (TCT) of 442 mm in the right eye and
a Kmax of 49.6 D and TCT of 432 mm in the left eye.
Topography could not be performed initially in the right eye
because of the lack of cooperation. In the left eye, measurements
revealed a keratometry of 46.1 D at 162 degrees in the steep
meridian (Ks), 43.1 D at 72 degrees in the ﬂat meridian (Kf), and an
average corneal power (AveK) of 44.6 D. Bilateral keratoconus was
diagnosed, being more pronounced in the left eye. A possible
treatment with CXL in the case of further progression was discussed
with the parents.
The follow-up examination after 3 months revealed pro-
gression of keratoconus in the left eye (Kmax 50.2 D, TCT 424 mm;
TMS Ks: 48.0 D at 169 degrees, Kf: 46.7 D at 79 degrees, AveK
47.3 D), shortly thereafter, epi-off CXL was performed under
general anesthesia using a standard Dresden protocol.6 Intraoperative
pachymetry was performed using a Tomey SP-100 ultrasound
pachymeter (Tomey), showing corneal thinning to 290 mm. Corneal
swelling was induced with hypoosmolar riboﬂavin. Repeated intra-
operative pachymetry revealed a thickness of 400 mm. The eye was
irradiated for 30 minutes with UV-A (3 mW/cm2, UV-X-1000;
IROC Innocross, Zug, Switzerland).
A year later, CXL was also performed in the right eye because
of progressive thinning and increasing curvature of the cornea
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FIGURE 1. Anterior corneal curvature (Kmax and AveK, A) and corneal thickness (thinnest point, B) before and after CXL. The
arrows show the time of CXL.
FIGURE 2. Preoperative (A) and postoperative (B) topographies (elevation, front) using the Pentacam (24-month follow-up in the
right eye and 36-month follow-up in the left eye).
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(Pentacam Kmax 48.1 D, TCT 405 mm; TMS Ks: 46.7 D at 3 degrees,
Kf: 46.2 D at 93 degrees, AveK 46.4 D). Intraoperative stromal
swelling with hypoosmolar 0.1% riboﬂavin was also needed for this
eye: the cornea had thinned to 388 mm and was swelled to 444 mm
before irradiation. No complications occurred during or after both
surgeries. The postoperative local treatment consisted of oﬂoxacin 5
times daily (Floxal UD; Bausch & Lomb, Zug, Switzerland) until
complete epithelialization and ﬂuorometholone 4 times daily (FML
Liquiﬁlm; Allergan, Pfaefﬁkon, Switzerland) during 1 month.
Topographic and tomographic measurements at the last
follow-up (ie, 2 years for the right eye and 3 years for the left
eye) are shown in Figures 1–3. A marked bilateral ﬂattening effect
was observed within the ﬁrst postoperative year. Topographies
stabilized over the next 2 years in the left eye, whereas slight
progression was observed during the second year of follow-up in the
right eye, but the values were still ﬂatter compared with preoperative
measurements (Fig. 1A). The corneal thickness remained stable after
initial thinning (Fig. 1B). Overall, Kmax decreased from 48.1 D to
46.8 D in the right eye and from 50.2 D to 49.4 D in the left eye
(Figs. 1A, 2A, 2B). AveK decreased from 46.4 D to 44.6 D in the
right eye and from 47.3 D to 45.1 D in the left eye (Figs. 1A, 3A,
3B). Stabilization of keratoconus was achieved in both eyes. The last
cycloplegic retinoscopy showed a refractive error of +2.5 in the right
eye and +5/21.5/90° in the left eye. The best-corrected near visual
acuity was 20/80 in both eyes.
DISCUSSION
We report the outcome of CXL in a 4-year-old child
with progressive keratoconus with a follow-up of 3 years.
This case demonstrates that keratoconus can be diagnosed at
a very young age. To our knowledge, this patient is one of the
youngest ever described. It may be speculated that Down
syndrome is a risk factor for the early onset of the disease; and
eye rubbing was never noted during visits or reported by the
parents. In our clinical experience, fast progression of
keratoconus as in this child is not untypical in very young
children. Hence, an early diagnosis and recognition of
progression are even more important.
FIGURE 3. Preoperative (A) and
postoperative (B) topographies
using TMS (24-month follow-up in
the right eye and 36-month follow-
up in the left eye).
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In our case, further keratoconus progression was
arrested and visual acuity was stabilized after CXL. As
described for older patients with keratoconus in previous
studies, the initial deterioration of all keratoconus indices,
probably induced by the epithelial debridement, was followed
by a continuous improvement of most of the indices during
the observed period.3 The marked corneal thinning after CXL
has also been described.3
Although transepithelial CXL might have some advan-
tages particularly in regard to complications and comfort,7 we
decided to perform epi-off CXL because of better evidence
for its efﬁcacy.8 Discussion about transepithelial CXL is
ongoing, especially because of the reduced penetration of
riboﬂavin through the intact epithelium and partial blockage
of UV-A light from reaching the stroma.9 In an animal model,
Wollensak and Iomdina10 revealed that corneal CXL without
epithelial debridement reduced the biomechanical effect by
approximately one-ﬁfth compared with standard epi-off CXL.
CXL is a very safe procedure when performed correctly, that
is, under sterile conditions and with postoperative topical
antibiotics. The risk for infectious keratitis is very low,
probably because of the fact that the treated patients are
young and without corneal surface problems, so that reepi-
thelialization is fast. When performing CXL in very young
children, such as in our case, the additional risks of general
anesthesia have to be taken into account.
Consistent topographic and tomographic measurements
can be challenging in young children, especially in those with
Down syndrome, because of poor ﬁxation and lack of
concentration. In our case, good measurements were obtained
thanks to a very cooperative and quiet girl, helpful parents,
and very experienced technicians. In our experience, repeated
measurements with several machines and on different days
may be necessary to diagnose and follow keratoconus in
young children.
Our case shows that standard epi-off CXL may be safe
and effective in arresting keratoconus progression in early
childhood.
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